Crossmark

Comparison of ceftriaxone plus macrolide and ampicillin/sulbactam plus macrolide in treatment for patients with community-acquired pneumonia without risk factors for aspiration: an open-label, quasi-randomized, controlled trial

Crossref DOI link: https://doi.org/10.1186/s12890-020-01198-4

Published Online: 2020-06-05

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hamao, Nobuyoshi

Ito, Isao

Konishi, Satoshi

Tanabe, Naoya

Shirata, Masahiro

Oi, Issei

Tsukino, Mitsuhiro

Matsumoto, Hisako

Yasutomo, Yoshiro

Kadowaki, Seizo

Hirai, Toyohiro
License Information

Text and Data Mining valid from 2020-06-05

Version of Record valid from 2020-06-05
More Information

Article History

Received: 16 February 2020

Accepted: 22 May 2020

First Online: 5 June 2020

Ethics approval and consent to participate

: The institutional review board of Ono Municipal Hospital approved the study protocol, and written informed consent was obtained from all patients. If the patient was under 20 years old, the written informed consent of their parent/s was also obtained. This study adheres to Consolidated Standards of Reporting Trials guideline.

: Not applicable.

: None declared.

Document is current

Any future updates will be listed below